Flucytosine Resistance Is Restricted to a Single Genetic Clade of Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 262-266

  Pujol, Claude ^a   Pfaller, Michael A ^b   Soll, David R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCYTOSINE;

ARTICLE; CANDIDA ALBICANS; CLADISTICS; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; FUNGAL GENETICS; FUNGAL STRAIN; FUNGUS ISOLATION; GENETIC RECOMBINATION; GENETIC TRAIT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; BLOTTING, SOUTHERN; CANDIDA ALBICANS; CANDIDIASIS; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG RESISTANCE, FUNGAL; FLUCYTOSINE; MICROBIAL SENSITIVITY TESTS;

EID: 0347992029     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.262-266.2004     Document Type: Article

References (36)

1. Abele-Horn, M., A. Kopp, U. Sternberg, A. Ohly, A. Dauber, W. Russwurm, W. Buchinger, O. Nagengast, and P. Emmerling. 1996. A randomized study comparing fluconazole with amphotericin B/5-fluorocytosine for the treatment of systemic Candida infections in intensive care patients. Infection 24:426-432.
2. Anderson, J., T. Srikantha, B. Morrow, S. H. Miyasaki, T. C. White, N. Agabian, J. Schmid, and D. R. Soll. 1993. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J. Clin. Microbiol. 31:1472-1480.
3. Auger, P., C. Dumas, and J. Joly. 1979. A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine. J. Infect. Dis. 139:590-594.
4. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
5. Blignaut, E., C. Pujol, S. R. Lockhart, S. Joly, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals new clade in South Africa. J. Clin. Microbiol. 40:826-836.
6. Cowen, L. E., C. Sirjusingh, R. C. Summerbell, S. Walmsley, S. Richardson, L. M. Kohn, and J. B. Anderson. 1999. Multilocus genotypes and DNA fingerprints do not predict variation in azole resistance among clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 43:2930-2938.
7. Drouhet, E., L. Mercier-Soucy, and S. Montplaisir. 1975. Sensibilité et résistance des levures pathogens aux 5-fluoropyrimidines. I. Relation entre les phenotypes de résistance à la 5-fluorocytosine, le sérotype de Candida albicans et l'écologie de différentes espèces de Candida d'origine humaine. Ann. Microbiol. 126B:25-39.
8. Gräser, Y., M. Volovsek, J. Arrington, G. Schönian, W. Presber, T. G. Mitchell, and R. Vilgalys. 1996. Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc. Natl. Acad. Sci. USA 93:12473-12477.
9. Hull, C. M., and A. D. Johnson. 1999. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 285:1271-1275.
10. Hull, C. M., R. M. Raisner, and A. D. Johnson. 2000. Evidence for mating of the "asexual" yeast Candida albicans in mammals. Science 289:307-310.
11. Lachke, S. A., S. R. Lockhart, K. J. Daniels, and D. R. Soll. 2003. Skin facilitates Candida albicans mating. Infect. Immun. 71:4970-4976.
12. Lockhart, S. R., K. J. Daniels, R. Zhao, D. Wessels, and D. R. Soll. 2003. Cell biology of mating in Candida albicans. Eukarot. Cell 2:49-61.
13. Lockhart, S. R., J. J. Fritch, A. S. Meier, K. Schröppel, T. Srikantha, R. Galask, and D. R. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Microbiol. 33:1501-1509.
14. Lockhart, S. R., C. Pujol, K. J. Daniels, M. G. Miller, A. D. Johnson, and D. R. Soll. 2002. In Candida albicans, white-opaque switchers are homozygous for mating type. Genetics 162:737-745.
15. Lott, T. J., B. P. Holloway, D. A. Logan, R. Fundyga, and J. Arnold. 1999. Towards understanding the evolution of the human commensal yeast Candida albicans. Microbiology 145:1137-1143.
16. Magee, B. B., and P. T. Magee. 2000. Induction of mating in Candida albicans by construction of MTLa and MTLa strains. Science 289:310-313.
17. Mercure, S., S. Montplaisir, and G. Lema. 1993. Correlation between the presence of a self-splicing intron in the 25S rDNA of C. albicans and strain susceptibility to 5-fluorocytosine. Nucleic Acids Res. 21:6020-6027.
18. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Pfaller, M. A., D. J. Diekema, R. N. Jones, H. S. Sader, A. C. Fluit, R. J. Hollis, S. A. Messer, and The SENTRY Participant Group. 2001. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J. Clin. Microbiol. 39:3254-3259.
20. Pfaller, M. A., S. A. Messer, L. Boyken, H. Huynh, R. J. Hollis, and D. J. Diekema. 2002. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46:3518-3521.
21. Poulain, D., V. Hopwood, and A. Vernes. 1985. Antigenic variability of Candida albicans. Crit. Rev. Microbiol. 12:223-270.
22. Pujol, C., S. Joly, S. R. Lockhart, S. Noel, M. Tibayrenc, and D. R. Soll. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35:2348-2358.
23. Pujol, C., S. Joly, B. Nolan, T. Srikantha, and D. R. Soll. 1999. Microevolutionary changes in Candida albicans identified by the complex Ca3 fingerprinting probe involve insertions and deletions of the full-length repetitive sequence RPS and specific genomic sites. Microbiology 145:2635-2646.
24. Pujol, C., S. A. Messer, M. Pfaller, and D. R. Soll. 2003. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans. Antimicrob. Agents Chemother. 47:1207-1212.
25. Pujol, C., M. Pfaller, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South America, and Europe reveals a European clade. J. Clin. Microbiol. 40:2729-2740.
26. Pujol, C., F. Reynes, M. Renaud, M. Raymond, M. Tibayrenc, F. J. Snyder, F. Janbon, M. Mallie, and J. M. Bastite. 1993. The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus positive patients. Proc. Natl. Acad. Sci. USA 90:9456-9459.
27. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Sinald, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro:in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
28. Sadhu, C., M. J. McEachern, E. P. Rustchenko-Bulgac, J. Schmid, D. R. Soll, and J. Hicks. 1991. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification. J. Bacteriol. 173:842-850.
29. Sanglard, D., and J. Bille. 2002. Current understanding of the modes of action of and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections, p. 349-383. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington D.C.
30. Schmid, J., E. Voss, and D. R. Soll. 1990. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J. Clin. Microbiol. 28:1236-1243.
31. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
32. Soll, D. R., S. R. Lockhart, and C. Pujol. 2003. Laboratory procedures for the epidemiological analysis of microorganisms, p. 139-161. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, vol. 1, 8th ed. American Society for Microbiology, Washington, D.C.
33. Soll, D. R., and C. Pujol. 2003. Candida albicans clades. FEMS Immunol. Med. Microbiol. 39:1-7.
34. Stiller, R. L., J. E. Bennett, H. J. Scholer, M. Wall, A. Polak, and D. A. Stevens. 1983. Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. J. Infect. Dis. 147:1070-1077.
35. Stiller, R. L., J. E. Bennett, H. J. Scholer, M. Wall, A. Polak, and D. A. Stevens. 1982. Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob. Agents Chemother. 22:482-487.
36. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.